Skip to main content

Table 1 Patient and procedure characteristics and outcomes

From: Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement

Characteristics

N = 9

Age

84.8 ± 5.1

Male

67 %

Euroscore (Logistic)

23.5 ± 12.5 %

Peripheral artery disease

11 %

End stage renal failure

0

Creatinine (mg/dL)

1.52 ± 0.6

LV-Ao peak gradient

66.4 ± 26.2

LV-Ao mean gradient

43.9 ± 18.2

AVA (cm2)

0.7 ± 0.1

Medtronic Corevalve Size

 

 26

22 %

 29

56 %

 31

22 %

Outcomes

 

 Post-TAVR LV-AO peak gradient

13.8 ± 6.4

 Death within 30 days

0

 Stroke/TIA

0

 MI

0

 Pacemaker

44 %

 Other Complications

11 %

  1. LV-AO left ventricle—aortic, AVA aortic valve area, TAVR transcatheter aortic valve replacement, TIA transient ischemic attack, MI myocardial infarction, AF atrial fibrillation. Other complications includes arrhythmias, major bleeding and renal failure